DIMPLE AGARWAL: Open Payments
NPI 1275632887 · PALM SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,276 in 99 payments from 25 companies in 2025. Trend: 2023 $2,499 · 2024 $2,002 · 2025 $2,276
Food & beverage: $2,209Education: $66
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $394 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $201 |
| Amgen Inc. | 15 | $180 |
| Novo Nordisk Inc | 10 | $164 |
| Viatris Specialty LLC | 10 | $138 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Lilly USA, LLC | 6 | $124 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Baxter Healthcare | 4 | $100 |
| Teva Pharmaceuticals USA, Inc. | 3 | $97 |
Products named: Kerendia, FARXIGA, AIRSUPRA, YUPELRI, UPTRAVI, Symbravo, OTEZLA, Korlym.
Industry payments across CA — which companies pay providers there.
